M. Peeters et al., Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease, AM J GASTRO, 96(3), 2001, pp. 730-734
OBJECTIVES: Correct diagnosis of inflammatory bowel disease (IBD), especial
ly the differentiation between Crohn's disease (CD) and ulcerative colitis
(UC), is highly important toward treatment and prognosis. Serological marke
rs are noninvasive diagnostic tools that could be of value in differentiati
ng CD from UC, in cases of indeterminate colitis, and in the identification
of subgroups in IBD. The aim of this study was to evaluate the diagnostic
accuracy of perinuclear antineutrophil cytoplasmic (pANCA) and anti-Sacchar
omyces cerevisiae antibodies (ASCA) for IBD.
METHODS: ASCA and pANCA were studied in a large cohort of consecutive IBD p
atients (n = 582: 407 CD, 147 UC, and 28 indeterminate colitis), patients w
ith non-IBD diarrheal illnesses (n = 74), and healthy controls (n = 157). A
n indirect immunofluorescence technique and a standardized ELISA were perfo
rmed for detection of pANCA and ASCA, respectively.
RESULTS: prevalence of ASCA and pANCA was high in CD patients (59.7%) and U
C (49.7%;) patients, respectively. Positivity for both markers was signific
antly lower in healthy and non-IBD controls. Accuracy data (sensitivity, sp
ecificity, PPV, and NPV, respectively) for differentiating IBD from control
s are as follows: ASCA(+): 60% (243/407), 91% (345/378), 88% (243/276), and
68% (345/509); pANCA(+): 50% (73/147), 95% (605/638), 69% (73/106), and 89
% (605/679); ASCA(+)/pANCA(-): 56% (229/407), 94% (355/378), 91% (229/252),
and 67% (355/533); and pANCA(+)/ASCA(-): 44% (65/147), 97% (620/638), 78%
(65/83), and 88% (620/702).
CONCLUSIONS: Specificity of serological markers for LED is high, but low se
nsitivity makes them less useful as diagnostic tests. The combination of te
sts is probably more powerful, although, clinical subgroups still need to b
e defined. The usefulness of these markers in indeterminate colitis needs t
o be studied prospectively. (C) 2001 by Am. Cell. of Gastroenterology.